How do I take Victoza®?

Victoza is an injectable medication for adults with type 2 diabetes

Victoza® is an injectable medication for adults with type 2 diabetes.
It is taken once a day. Victoza® is delivered with the Victoza® Pen.

Learn more about using the Victoza® Pen

When Is the Best Time to Take Victoza®?

You must take Victoza® every day as recommended by your healthcare professional, so it is best to take it at a time that you will remember to take it. The important thing is to get into a routine and take Victoza® once a day, with or without food. You do not have to adjust your dose based on what you eat or how active you are.

What Do I Need to Know About the Victoza® Pen?

Your healthcare provider must teach you how to inject Victoza® before you use it for the first time. If you have questions or do not understand the instructions, talk to your healthcare provider or pharmacist.

  • Pen needles are sold separately and may require a prescription in some states. Ask your healthcare provider which needle size is best for you.
  • The needle recommended for use with the Victoza® Pen (32-gauge Tip) is the thinnest Pen needle from Novo Nordisk available in the US
  • The majority of people studied using a 32-gauge Tip needle experienced little or no pain*
  • When starting to use a new prefilled Victoza® Pen, you must follow the “First-Time Use for Each New Pen” instructions that come with it. You only need to do this 1 time with each new Pen. You should also follow these instructions if you drop your Pen. If you follow the “First Time Use for Each New Pen” instructions before each injection, however, you will run out of medication too soon.

Learn how to prepare for your first injection

Support is a phone call away

VictozaCare Coaches and trained diabetes educators, nurses, and dieticians provide Pen training support, answer questions about Victoza®, and offer tips to help manage type 2 diabetes.

SIGN UP NOW

Or contact a VictozaCare Coach at 1-877-4-VICTOZA (1-877-484-2869), Monday through Friday.

*Multicenter, randomized, open-label, 2-period, crossover trial in insulin-treated patients with diabetes (type 1 or type 2). Patients were randomized to self-administer insulin injections with one needle type followed by the alternative, each for 7-14 days. The 2 needle types used were NovoFine® 32-gauge Tip x 6 mm and NovoFine® 30-gauge Tip x 8 mm.

After the first 2 or 3 injections of using Victoza® ...  I felt that I was heading in the right direction.

Patient stories

Watch Lynn G. and others discuss their first Victoza® injection.

Using your Victoza® Pen

Get detailed information about the right way to use your Victoza® Pen, including a video demonstration.

Start here

Indications and Usage

Victoza® is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes when used along with diet and exercise.

Victoza® is not recommended as the first medication to treat diabetes. Victoza® is not insulin and has not been studied in combination with insulin. Victoza® is not for people with type 1 diabetes or people with diabetic ketoacidosis. It is not known if Victoza® is safe and effective in children. Victoza® is not recommended for use in children.

Important Safety Information

In animal studies, Victoza® caused thyroid tumors—including thyroid cancer—in some rats and mice. It is not known whether Victoza® causes thyroid tumors or a type of thyroid cancer called medullary thyroid cancer (MTC) in people which may be fatal if not detected and treated early. Do not use Victoza® if you or any of your family members have a history of MTC or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). While taking Victoza®, tell your doctor if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.

Inflammation of the pancreas (pancreatitis) may be severe and lead to death. Before taking Victoza®, tell your doctor if you have had pancreatitis, gallstones, a history of alcoholism, or high blood triglyceride levels since these medical conditions make you more likely to get pancreatitis.

Stop taking Victoza® and call your doctor right away if you have pain in your stomach area that is severe and will not go away, occurs with or without vomiting, or is felt going from your stomach area through to your back. These may be symptoms of pancreatitis.

Before using Victoza®, tell your doctor about all the medicines you take, especially sulfonylurea medicines or insulin, as taking them with Victoza® may affect how each medicine works.

Also tell your doctor if you are allergic to any of the ingredients in Victoza®; have severe stomach problems such as slowed emptying of your stomach (gastroparesis) or problems with digesting food; have or have had kidney or liver problems; have any other medical conditions; are pregnant or plan to become pregnant. Tell your doctor if you are breastfeeding or plan to breastfeed. It is unknown if Victoza® will harm your unborn baby or if Victoza® passes into your breast milk.

Your risk for getting hypoglycemia, or low blood sugar, is higher if you take Victoza® with another medicine that can cause low blood sugar, such as a sulfonylurea. The dose of your sulfonylurea medicine may need to be lowered while taking Victoza®.

Victoza® may cause nausea, vomiting, or diarrhea leading to dehydration, which may cause kidney failure. This can happen in people who have never had kidney problems before. Drinking plenty of fluids may reduce your chance of dehydration.

The most common side effects with Victoza® include headache, nausea, and diarrhea. Nausea is most common when first starting Victoza®, but decreases over time in most people. Immune system related reactions, including hives, were more common in people treated with Victoza® compared to people treated with other diabetes drugs in medical studies.

Please click here for Prescribing Information and Medication Guide.

Novo Nordisk provides patient assistance for those who qualify.
Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch fda medwatch, or call 1-800-FDA-1088.